Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib Limei Hu, Youjun Xie, Hongying Zhao

Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib O.F. Olmez, A. Bilici, P. Gursoy, E. Cubukcu, A. Sakin, T. Korkmaz, I. Cil, B. Cakar, S. Menekse, T. Demir, O. Acikgoz, J. Hamdard

Treatment of lung cancer during pregnancy A. Soares, J. dos Santos, A. Silva, H. Magalhães, F. Estevinho, C. Sottomayor